Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Youth soccer players need longer rest periods to prevent injury and ensure optimal recovery

Study reveals significant post-match declines in performance and muscle damage in elite youth soccer players, emphasizing the need for extended recovery periods beyond the commonly assumed 48 hours.

29 Aug 2024

Research highlights potential of blood epigenetics for dementia risk assessment

New research suggests that epigenetic markers in the blood could be useful for understanding dementia risk.

28 Aug 2024

Synexa Life Sciences enrols in My Green Lab certification program

Synexa Life Sciences, a global provider of biomarker and bioanalytical solutions to the pharmaceutical, biotech, and CRO industries, proudly announces its enrolment in the My Green Lab Certification Program.

From Synexa Life Sciences 28 Aug 2024

Improved IVF success with the Mediterranean diet, study shows

Review highlights that adherence to the Mediterranean diet may improve clinical pregnancy and live birth rates in couples undergoing assisted reproduction, though findings are inconsistent, and more research is needed.

27 Aug 2024

Green Heart Louisville Project links more trees to lower inflammation levels

The University of Louisville's groundbreaking Green Heart Louisville Project has found that people living in neighborhoods where the number of trees and shrubs was more than doubled showed lower levels of a blood marker of inflammation than those living outside the planted areas.

27 Aug 2024

Exploring early detection of Alzheimer's disease through non-cognitive symptoms

The article presents a thorough examination of Alzheimer's disease (AD), emphasizing early detection as critical due to the disease's progression through stages from normal cognition to mild cognitive impairment (MCI) and eventually dementia.

26 Aug 2024

Innovations in biomarker detection and personalized medicine for prostate cancer

In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application of biomarkers for prostate cancer (PCa).

23 Aug 2024

Olaparib effective against BRCA2-mutated prostate cancer

The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients conducted at the Johns Hopkins Kimmel Cancer Center and three other sites.

23 Aug 2024

Rising IBD incidence highlights need for non-invasive biomarkers in diagnosis

The global burden of inflammatory bowel diseases (IBD), primarily Crohn's disease (CD) and ulcerative colitis (UC), continues to rise. Recent data show incidence rates of up to 17.8 cases per 100,000 person-years for CD and even higher for UC, reaching 28.4 per 100,000 person-years. These diseases primarily affect older populations and vary geographically, with higher prevalence rates in highly developed countries.

23 Aug 2024

Experts release revised lung cancer testing guidelines

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period for the revised 2018 evidence-based guideline, "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors."

23 Aug 2024

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

Researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson's disease.

22 Aug 2024

Progress and future directions in esophageal cancer screening in China

Esophageal cancer, a highly aggressive malignancy originating in the esophageal epithelium, poses significant public health challenges in China, where it ranks sixth in incidence and fifth in mortality among cancers.

20 Aug 2024

Researchers reveal impact of genetic ancestry on breast cancer risk and cell diversity

Researchers map the diverse cell types present in healthy breast tissue to elucidate the role of genetic ancestry in breast cancer risk.

20 Aug 2024

Metabolomics links increased heme iron intake to increased insulin-independent type 2 diabetes risk

Researchers utilie metabolomics to investigate the processes underlying dietary heme iron consumption and the risk of type 2 diabetes.

20 Aug 2024

New insights into the role of vascular adhesion molecules in cardiovascular diseases

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Vascular Adhesion Molecules (VAMs) appear to play important roles in the development of Cardiovascular Diseases (CVD).

19 Aug 2024

Lexogen Launches RiboCop rRNA Depletion Kit for Fish Species

Lexogen, a leader in RNA sequencing technologies, is thrilled to announce the launch of the RiboCop rRNA Depletion Kit for Fish, a dedicated solution to facilitate transcriptome analysis of fish species by effectively removing unwanted ribosomal RNA (rRNA) from total RNA samples.

From Lexogen 19 Aug 2024